What happened
A California jury ordered Apple to pay Masimo $634 million for patent infringement concerning blood oxygen monitoring technology in Apple Watches. This ruling follows a 2020 lawsuit and a prior International Trade Commission (ITC) import ban on Apple's Series 9 and Ultra 2 watches. The infringement specifically relates to Apple's workout mode and heart rate notifications, despite Apple having updated and reintroduced its blood oxygen technology. Apple intends to appeal the decision.
Why it matters
This verdict introduces a significant financial liability constraint for Apple, directly impacting its legal and financial departments. The ongoing legal dispute and potential for further ITC review on updated watch models increase due diligence requirements for product development and intellectual property teams regarding feature implementation and patent clearance. This also creates an oversight burden for procurement and supply chain operations concerning component sourcing and market availability.
Subscribe for Weekly Updates
Stay ahead with our weekly AI and tech briefings, delivered every Tuesday.
